Medicin og biovidenskab
Cost-Benefit Analysis
100%
General Practice
78%
Defensive Medicine
78%
General Practitioners
62%
Denmark
43%
Chronic Obstructive Pulmonary Disease
41%
Case Management
40%
Costs and Cost Analysis
39%
Referral and Consultation
33%
Quality-Adjusted Life Years
31%
Low Back Pain
31%
Randomized Controlled Trials
29%
Primary Health Care
29%
Diabetic Foot
18%
Latent Class Analysis
17%
Focus Groups
17%
Health Insurance
16%
Cross Infection
15%
Uncertainty
14%
Health
13%
Population
12%
Logistic Models
12%
Health Care Sector
11%
Secondary Care
11%
Interviews
10%
Technology
10%
Self Care
10%
Guidelines
9%
Sex Education
9%
Pressure
9%
Statistics
9%
Delivery of Health Care
8%
Organizations
7%
National Institutes of Health (U.S.)
6%
Health Care Outcome Assessment
6%
Income
6%
Ambulatory Care Facilities
6%
Point-of-Care Systems
5%
Practice Guidelines
5%
Education
5%
Health Care Costs
5%
Hematologic Tests
5%
Hospital Medicine
5%
Regression Analysis
5%
Samfundsvidenskab
general practitioner
36%
costs
29%
Denmark
28%
case management
23%
life years
20%
evaluation
19%
medical technology
19%
experiment
18%
segmentation
17%
working life
17%
medicine
15%
pain
14%
health care
14%
economics
14%
Health Economics
9%
logistics
6%
health
6%
time
6%
interview
6%
regression
5%
statistics
5%
Erhverv og økonomi
Hybrid Model
23%
Time Trade-off
23%
Quality-adjusted Life Years
21%
Economies of Scale and Scope
20%
Case Management
19%
Discrete Choice Experiment
19%
Hospital Services
18%
Community-based
17%
Economic Evaluation
16%
Cost-effectiveness Ratio
15%
Incremental Cost
13%
Denmark
8%
Health State
8%
General Population
7%
Medicine
5%
